These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18683083)

  • 1. American Society of Clinical Oncology--44th Annual Meeting. Reports of clinical trial results--part 1.
    Searle B
    IDrugs; 2008 Aug; 11(8):545-6. PubMed ID: 18683083
    [No Abstract]   [Full Text] [Related]  

  • 2. American Society of Clinical Oncology--44th Annual Meeting. Reports of clinical trial results--part 2.
    Ogbighele E
    IDrugs; 2008 Aug; 11(8):547-9. PubMed ID: 18683084
    [No Abstract]   [Full Text] [Related]  

  • 3. American Society of Clinical Oncology--44th Annual Meeting. Target identification and data from preclinical and clinical studies.
    Kibble A
    IDrugs; 2008 Aug; 11(8):541-4. PubMed ID: 18683082
    [No Abstract]   [Full Text] [Related]  

  • 4. American society of clinical oncology - 45th annual meeting. Part 2.
    Lakeram M; Kibble A
    IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155
    [No Abstract]   [Full Text] [Related]  

  • 5. American society of clinical oncology - 45th annual meeting. Part 1.
    Gale S
    IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154
    [No Abstract]   [Full Text] [Related]  

  • 6. American society of clinical oncology--41st annual meeting. Immunology.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):528-30. PubMed ID: 15973554
    [No Abstract]   [Full Text] [Related]  

  • 7. American Society of Clinical Oncology--46th annual meeting.
    Al-Shamahi A; Murch L; Kirkham K
    IDrugs; 2010 Aug; 13(8):506-9. PubMed ID: 20721815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One community. The B. Chevalier Lecture, held at the EORTC New Drugs Meeting, Lugano, Switzerland, 19-21 June 1997.
    Wittes RE; Yoder O
    Ann Oncol; 1998 Mar; 9(3):251-4. PubMed ID: 9602257
    [No Abstract]   [Full Text] [Related]  

  • 9. Reviewing concomitant medications for participants in oncology clinical trials.
    McGahey KE; Weiss GJ
    Am J Health Syst Pharm; 2017 Apr; 74(8):580-586. PubMed ID: 28389457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
    Morgensztern D; Pennell NA; Subramanian J; Govindan R
    Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New scale assesses benefits of cancer medicines.
    Bagcchi S
    Lancet Oncol; 2015 Jul; 16(7):e316. PubMed ID: 26051234
    [No Abstract]   [Full Text] [Related]  

  • 12. Diflomotecan. Ipsen.
    Osheroff N
    IDrugs; 2004 Mar; 7(3):257-63. PubMed ID: 15011101
    [No Abstract]   [Full Text] [Related]  

  • 13. Learning from exceptional drug responders.
    Mullard A
    Nat Rev Drug Discov; 2014 Jun; 13(6):401-2. PubMed ID: 24875081
    [No Abstract]   [Full Text] [Related]  

  • 14. American society of clinical oncology--41st annual meeting.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):525-7. PubMed ID: 15973553
    [No Abstract]   [Full Text] [Related]  

  • 15. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA.
    Mitra AP
    IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310
    [No Abstract]   [Full Text] [Related]  

  • 16. Researchers may use cancer cell lines to identify target populations prior to clinical trials.
    Tuma RS
    J Natl Cancer Inst; 2006 Jun; 98(12):810-1. PubMed ID: 16788154
    [No Abstract]   [Full Text] [Related]  

  • 17. American Society of Clinical Oncology--41st annual meeting. Drug highlights II.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):534-6. PubMed ID: 15973556
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel targeted cancer drugs highlighted.
    Hampton T
    JAMA; 2006 Jul; 296(3):270. PubMed ID: 16849654
    [No Abstract]   [Full Text] [Related]  

  • 19. SOP 12: Validation of bioanalytical methods.
    Onkologie; 2003 Oct; 26 Suppl 6():52-5. PubMed ID: 23570189
    [No Abstract]   [Full Text] [Related]  

  • 20. 27th Annual JPMorgan Healthcare Conference--Antisoma and Keryx Biopharmaceuticals.
    Croasdell G; Gale S
    IDrugs; 2009 Mar; 12(3):152-4. PubMed ID: 19333892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.